Test Catalog

Test ID: HIVI    
HIV-1 Genotypic Integrase Inhibitor Drug Resistance, Plasma

Useful For Suggests clinical disorders or settings where the test may be helpful

Identification of HIV-1 genotypic mutations in the integrase region of HIV-1 to predict antiretroviral drug resistance in HIV-1-infected patients receiving integrase strand transfer inhibitors (ie, bictegravir, dolutegravir, elvitegravir, raltegravir)


Guiding initiation or change of drug combinations for the treatment of HIV-1 infection

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

See HIV Treatment Monitoring Algorithm in Special Instructions.

Special Instructions Library of PDFs including pertinent information and forms related to the test

Method Name A short description of the method used to perform the test

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)/DNA Sequencing

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

HIV-1 Genotypic Integrase Resist, P

Aliases Lists additional common names for a test, as an aid in searching

AIDS (acquired immune deficiency syndrome)
HIV-1 Genotyping
HIV-1 Resistance
HIV-1 Drug Resistance Mutation Analysis
HIV-1 Genotyping for Drug Resistance
HIV-1 Mutation Analysis
HIV-1 integrase (INT) mutations
HIV-1 integrase inhibitor (INTI) resistance
Human Immunodeficiency Virus type 1 (HIV)